IMVT · Immunovant, Inc. · Investor Relations
$31.77
-0.75 (-2.31%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$6.57B
Shares
206.95M
Volume · Nov 20
704.94K
Avg daily vol (3M)
1.41M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-09 | Roivant 2Q 2026 Earnings Call | Earnings call |
| 2026-09-02 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-08-06 | Roivant 1Q 2026 Earnings Call | Earnings call |
| 2026-05-20 | Roivant 4Q 2025 Earnings Call | Earnings call |
| 2026-04-02 | Roivant Investor Call | Event |
| 2026-02-06 | Roivant 3Q 2025 Earnings Call | Earnings call |
Key facts
CIK
1764013
CUSIP
45258J102
13F (30d)
239 filings
222 filers
Visit website
Investor relations